Related Experiment Videos
Association Between Opioid Use Disorder and Hysterectomy Outcomes
Stephanie L Lim1, Natalie Wickenheisser, Tracy Truong
1Division of Minimally Invasive Gynecologic Surgery, Department of Obstetrics and Gynecology, and the Department of Obstetrics and Gynecology, Duke University Medical Center, and the Department of Biostatistics & Bioinformatics, Duke University, Durham, North Carolina.
Obstetrics and Gynecology
|August 6, 2026
Summary
Patients with opioid use disorder (OUD) face higher complication risks and costs after hysterectomy. This highlights the need for enhanced preoperative care for OUD patients undergoing this surgery.
Area of Science:
- Gynecologic Surgery
- Addiction Medicine
- Health Services Research
Background:
- Opioid use disorder (OUD) is a growing public health concern impacting various medical procedures.
- Hysterectomy, a common gynecologic surgery, may have different outcomes in patients with OUD.
Purpose of the Study:
- To investigate the association between opioid use disorder (OUD) and postoperative complications, length of stay, and hospital charges following hysterectomy.
- To compare outcomes for patients with and without OUD undergoing both inpatient and outpatient hysterectomy.
Main Methods:
- Retrospective cohort study utilizing the Nationwide Ambulatory Surgery Sample and National Inpatient Sample databases (2016-2021).
- Inclusion of adult patients undergoing various types of hysterectomy (open, laparoscopic, robotic, vaginal) for benign and malignant indications.
- Analysis using survey-weighted regression models, adjusting for demographics and comorbidities, to assess complication rates, length of stay, and hospital charges.
Main Results:
- Patients with OUD undergoing outpatient hysterectomy showed a slightly higher complication rate (3.8% vs. 3.4%) but similar charges compared to those without OUD.
- In the inpatient cohort, patients with OUD experienced significantly higher complication rates (14.7% vs. 11.8%), longer lengths of stay (4.3 vs. 3.2 days), and increased hospital charges ($91,258 vs. $71,809).
- The study analyzed data from over 1.6 million outpatient and 188,000 inpatient procedures.
Conclusions:
- Patients with opioid use disorder (OUD) are at an elevated risk for postoperative complications following hysterectomy, regardless of surgical setting.
- OUD is associated with increased length of stay and higher hospital costs for inpatient hysterectomy patients.
- Preoperative optimization and patient education may be crucial for improving outcomes in patients with OUD undergoing hysterectomy.
Related Concept Videos
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...